Ulipristal acetate (Esmya®) single course treatment

Assessment Status Rapid review complete
Drug Ulipristal acetate
Brand Esmya®
Indication For the pre-operative treatment of moderate to severe symptoms of uterine fibroids in adult women of reproductive age.
Assessment Process
Rapid review commissioned 03/09/2013
Rapid review completed 18/10/2013
Rapid review outcome Full Pharmacoeconomic Evaluation Not Recommended